Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208049 · ClinicalTrials.gov registry record · NA
Predictors of Response to Insomnia Treatments for Gulf War Veterans
A NA study of Insomnia, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT03208049: Completed NA study of Insomnia, sponsored by VA Office of Research and Development.
NCT03208049 is a NA study of Insomnia that has completed, run by VA Office of Research and Development. The registered enrollment target is 50 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03208049, a NA study of Insomnia, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the efficacy and effectiveness of Behavioral Therapy (BT) and Cognitive Therapy (CT) in Gulf War Veterans with insomnia. The Primary Outcome measure is the Insomnia Severity Index (ISI).
Primary Outcome
Measure Description: This seven-item questionnaire asks respondents to rate the nature and symptoms of their sleep problems using a Likert scale. Questions relate to subjective qualities of sleep, including the severity of symptoms, the satisfaction with sleep patterns, the degree to which insomnia interferes with daily functioning, how noticeable the respondent feels his or her insomnia is to others, and the overall level of distress created by the sleep problem. Responses can range from zero t
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Therapy (BT)
- BEHAVIORAL Cognitive Therapy (CT)
Study Locations (3)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
District of Columbia
- Washington DC VA Medical Center, Washington, DC - Washington D.C.
New Jersey
- East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ - East Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2023-05-21 |
| Phase | NA |
What the finished NCT03208049 record still lists
NCT03208049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Therapy (BT) is the first listed.
NCT03208049 reports a single indexed study location in California, District of Columbia, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03208049 about?
NCT03208049 is a clinical study titled "Predictors of Response to Insomnia Treatments for Gulf War Veterans". The purpose of this study is to evaluate the efficacy and effectiveness of Behavioral Therapy (BT) and Cognitive Therapy (CT) in Gulf War Veterans with insomnia. The Primary Outcome measure is the Insomnia Severity Index (ISI).
What is the current status of trial NCT03208049?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-08-01. Estimated completion is 2023-05-21.
What conditions does trial NCT03208049 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT03208049?
The interventions under investigation include: Behavioral Therapy (BT) (BEHAVIORAL), Cognitive Therapy (CT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03208049?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03208049 being conducted?
This trial has 3 study locations across California, District of Columbia, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03208049's enrollment target sits among peer trials
50 103rd of 151 higher than 46 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI